Knowledge Hub

PharmSource - Follow The Money: The Outlook For Outsourced Spending On Early Development Services

Press Release   •   Feb 15, 2017 00:45 EST

MarketResearchReports.Biz has announced addition of new report “PharmSource - Follow The Money: The Outlook For Outsourced Spending On Early Development Services” to its database.

PharmSource - Follow the Money: The Outlook for Outsourced Spending on Early Development Services

Summary

Demand for development services to support Phase 1 and Phase 2 clinical trials is driving double-digit growth for CROs and CDMOs. Demand for clinical manufacturing services is actually outstripping industry capacity and leading to delays in getting clinical trial materials needed for studies.

According to this latest report, "PharmSource - Follow the Money: The Outlook for Outsourced Spending on Early Development Services", the driver of this early development activity has been the huge level of external funding flowing into emerging bio/pharma companies from venture capitalists and public markets. However, external funding for bio/pharma has always been a boom or bust proposition, and the likelihood that funding will be cut drastically always lurks on the horizon. This makes it difficult for CDMOs and CROs to pull the trigger on investments in new capacity.

Click here to know more about this report: http://www.marketresearchreports.biz/analysis/964481

Scope

- Follow the Money: The Outlook for Outsourced Spending on Early Development Services exams the link between external funding sources and early drug development, and addresses the outlook for continued funding over the next two years.

Reasons to buy

This report provides important insight that you wont find in any other source. This report is required reading for -

- CDMOs and CROs: market trends, capital investment decision-making, strategic planning, performance benchmarking

- Bio/pharma: supplier performance benchmarking, market trends, competitive intelligence

- Private equity: investment targeting, portfolio company performance benchmarking

Request a sample copy of this report: http://www.marketresearchreports.biz/sample/sample/964481

Table of contents:

  • Executive Summary 1
  • Context and Objectives 2
  • Clinical Trial Activity of Emerging Bio/Pharma Companies 4
  • Clinical Development Costs and Spending by Emerging Bio/Pharma Companies 7
  • External Financing for Emerging Bio/Pharma Companies 9
  • Outlook and What it Means 15
  • Appendix A 18
  • Appendix B 19

1.1 List of Tables

  • Table 1 2016 Performance of Drug Development Service Providers
  • Table 2 Profile of Emerging Bio/Pharma IPOs 2014-2015Executive Summary 1
  • Context and Objectives 2
  • Clinical Trial Activity of Emerging Bio/Pharma Companies 4
  • Clinical Development Costs and Spending by Emerging Bio/Pharma Companies 7
  • External Financing for Emerging Bio/Pharma Companies 9
  • Outlook and What it Means 15
  • Appendix A 18
  • Appendix B 19

1.1 List of Tables

  • Table 1 2016 Performance of Drug Development Service Providers
  • Table 2 Profile of Emerging Bio/Pharma IPOs 2014-2015

About Us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Latest Industry Press Release http://www.marketresearchreports.biz/pressreleases

Contact Us

State Tower

90 State Street, Suite 700

Albany, NY 12207

United States

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

Email: sales@marketresearchreports.biz

Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz